ADJUVANT EFFECT OF LUCANTHONE (MIRACIL-D) IN CLINICAL RADIATION-THERAPY

被引：32

作者：

TURNER, S

BASES, R

PEARLMAN, A

NOBLER, M

KABAKOW, B

机构：

[1] BETH ISRAEL MED CTR,DEPT MED,NEW YORK,NY 10003

[2] BETH ISRAEL MED CTR,DEPT RADIOTHERAPY,NEW YORK,NY 10003

[3] ALBERT EINSTEIN COLL MED,DEPT RADIOL,1300 MORRIS PK AVE,BRONX,NY 10461

来源：

RADIOLOGY | 1975年 / 114卷 / 03期

关键词：

D O I：

10.1148/114.3.729

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：729 / 731

页数：3

共 10 条

[1]

BASES R, 1970, CANCER RES, V30, P2007

[2] COMBINED LETHAL EFFECTS OF LUCANTHONE (MIRACIL-D) AND TOTAL-BODY IRRADIATION IN MICE [J].

BASES, R .

RADIOLOGY, 1972, 102 (01) :193-&

[3] REVERSIBLE INHIBITION OF RIBOSOMAL RNA SYNTHESIS IN HELA BY LUCANTHONE (MIRACIL-D) WITH CONTINUED SYNTHESIS OF DNA-LIKE RNA [J].

BASES, R ;

MENDEZ, F .

JOURNAL OF CELLULAR PHYSIOLOGY, 1969, 74 (03) :283-&

[4]

BLAIR D M, 1958, Bull World Health Organ, V18, P989

[5]

HACKMANN C., 1949, NATURWISS, V36, P29

[6]

KIM SH, 1973, CANCER, V32, P536, DOI 10.1002/1097-0142(197309)32:3<536::AID-CNCR2820320304>3.0.CO

[7]

2-E

[8]

VOICULETZ N, 1974, CANCER RES, V34, P1038

[9]

WEINSTEIN IB, 1965, MOL PHARMACOL, V1, P297

[10]

1972, MUTAT RES, V14, P315

← 1 →